Improving Physical Function in Skilled Nursing Facility Residents
SNF
1 other identifier
interventional
153
1 country
1
Brief Summary
Each year Medicare spends approximately $31.3 billion on 2.4 million skilled nursing facility (SNF) episodes of care. SNFs rely on interdisciplinary approaches to patient care to maximize rehabilitation potential for return to prior level of function and reduce the risk of adverse events in older adults. However despite a substantial increase in spending on SNF services and minimal change in complexity of the caseload, 68% of patients are below their pre-hospitalization level of function at discharge, 25% return to the community, and 18% are hospitalized. This may be partially explained by current SNF approaches to patient care which foster inactivity and participation in low intensity rehabilitation interventions (preliminary data). Both inactivity and low-intensity interventions may perpetuate further functional decline or impede maximal recovery. The serious implication of risk with functional decline is exemplified by studies which have shown declines in physical function can increase the risk of being re-hospitalized six-fold and may infer other long term effects such as increased risk for mortality, morbidity, and institutionalization. Muscle weakness, reduced cardiorespiratory reserve, and neuromuscular deficits have been attributed to this acute decline in function. However current rehabilitation strategies in SNFs do not promote adequate dose and mode of interventions to induce beneficial systemic adaptations, perhaps due to the lack of evidence on effective rehabilitation protocols for this medically-complex population. Therefore, the investigators have designed an rehabilitation program, which uniquely integrates principles of physiologic tissue overload with strengthening and functional interventions for greater gains in physical function. Data will be collected on the first cohort of patients who cycle through a SNF during Stage 1, in which usual care occurs (5 months). Then, staff training on progressive rehabilitation interventions will occur over 2 months. Finally, data will be collected on a second cohort of patients who cycle through a SNF during Stage 2, in which progressive rehabilitation is implemented by SNF staff (5 months). Given the high turnover of patients in SNFs (average length of stay \~21 days), 2 different cohorts of patients will be studied and the analysis will consist of independent 2-sample t-tests. During Stage 1 and 2, measures of physical function will be assessed on all eligible patients at admission and discharge from SNF. Therapists will be assessed on adherence to the protocol through documentation audits and use of on-site observational checklist. Acceptability of the intervention by the patients will be assessed by a patient satisfaction survey. Any adverse events will be obtained from the medical record and documented. The discharge location of all patients will be documented.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedNovember 15, 2016
November 1, 2016
1.6 years
March 13, 2015
November 11, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Short Physical Performance Battery (SPPB)
Global measure of lower extremity function, which consists of walking speed, chair stands, and balance tests
Change from Admission to Discharge (expected average length of stay 21 days)
Secondary Outcomes (1)
Gait Speed
Change from Admission to Discharge (expected average length of stay 21 days)
Other Outcomes (3)
Patient Satisfaction Survey
Discharge (expected average length of stay 21 days)
Therapist Intervention Compliance
Bi-weekly for 5 months during intervention arm
Discharge Location
Discharge (expected average length of stay 21 days)
Study Arms (2)
Usual Care
NO INTERVENTIONSNF rehabilitation therapists provide all patients with usual standard of care.
Progressive Rehabilitation
EXPERIMENTALSNF rehabilitation therapists have been trained on principles of progressive rehabilitation strategies and will implement to all eligible patients as new standard of care.
Interventions
Progressive, high-intensity strengthening and functional interventions to facilitate independence with functional activities.
Eligibility Criteria
You may qualify if:
- Adults older ≥55 years of age who are admitted to a skilled nursing facility following hospitalization
- Qualify to receive at least physical therapy services.
You may not qualify if:
- Patients with primary diagnoses related to neurological disorders will be excluded as patient needs require more of a motor-control approach versus the proposed high-intensity approach. Such patient populations include:
- Parkinson's Disease
- Traumatic Brain Injury
- Recent Cerebral Vascular Accident
- Alzheimer's
- Patients on hospice care will be excluded as the approach is based on palliative principles. Other patients to be excluded will include those with conditions where strength training is contraindicated (as indicated by the American College of Sports Medicine Guidelines for Exercise Testing and Prescription):
- Recent unstable fractures
- Advanced congestive heart failure (ejection fracture \<30%)
- Bone metastasis sites
- Tumors in strengthening target areas
- Acute illness
- Recent myocardial infarction (within 3-6 weeks)
- Weight bearing restrictions on graft or fracture sites
- Exposed tendon or muscle
- Absence of pedal pulses
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gardens on Quail
Arvada, Colorado, 80004, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Stevens-Lapsley, PT, PhD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2015
First Posted
April 21, 2015
Study Start
April 1, 2015
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
November 15, 2016
Record last verified: 2016-11